Search Results - "Kobashigawa, Jon A"

Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations by VanWagner, Lisa B., Harinstein, Matthew E., Runo, James R., Darling, Christopher, Serper, Marina, Hall, Shelley, Kobashigawa, Jon A., Hammel, Laura L.

“…Liver transplant (LT) candidates today are older, have greater medical severity of illness, and have more cardiovascular comorbidities than ever before. In…”
Get full text

International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy—2010 by Mehra, Mandeep R., MD, Crespo-Leiro, Maria G., MD, Dipchand, Anne, MD, Ensminger, Stephan M., MD, PhD, Hiemann, Nicola E., MD, Kobashigawa, Jon A., MD, Madsen, Joren, MD, PhD, Parameshwar, Jayan, MD, Starling, Randall C., MD, MPH, Uber, Patricia A., BS, PharmD

“…The development of cardiac allograft vasculopathy remains the Achilles heel of cardiac transplantation. Unfortunately, the definitions of cardiac allograft…”
Get full text

Complement inhibition for prevention of antibody‐mediated rejection in immunologically high‐risk heart allograft recipients by Patel, Jignesh K., Coutance, Guillaume, Loupy, Alexandre, Dilibero, Deanna, Hamilton, Michele, Kittleson, Michelle, Kransdorf, Evan, Azarbal, Babak, Seguchi, Osamu, Zhang, Xiaohai, Chang, David, Geft, Dael, Czer, Lawrence, Varnous, Shaida, Kobashigawa, Jon A.

“…Allosensitization represents a major barrier to heart transplantation (HTx). We assessed the efficacy and safety of complement inhibition at transplant in…”
Get full text

Interagency registry for mechanically assisted circulatory support report on the total artificial heart by Arabía, Francisco A., Cantor, Ryan S., Koehl, Devin A., Kasirajan, Vigneshwar, Gregoric, Igor, Moriguchi, Jaime D., Esmailian, Fardad, Ramzy, Danny, Chung, Joshua S., Czer, Lawrence S., Kobashigawa, Jon A, Smith, Richard G., Kirklin, James K.

“…We sought to better understand the patient population who receive a temporary total artificial heart (TAH) as bridge to transplant or as bridge to decision by…”
Get full text

Calculated panel-reactive antibody predicts outcomes on the heart transplant waiting list by Kransdorf, Evan P., MD, PhD, Kittleson, Michelle M., MD, PhD, Patel, Jignesh K., MD, PhD, Pando, Marcelo J., PhD, Steidley, D. Eric, MD, Kobashigawa, Jon A., MD

“…Background Sensitized heart transplant candidates spend more time and have higher mortality on the waiting list. Although the calculated panel-reactive…”
Get full text

Temporal Trends of De Novo Malignancy Development After Heart Transplantation by Youn, Jong-Chan, Stehlik, Josef, Wilk, Amber R., Cherikh, Wida, Kim, In-Cheol, Park, Gyeong-Hun, Lund, Lars H., Eisen, Howard J., Kim, Do Young, Lee, Sun Ki, Choi, Suk-Won, Han, Seongwoo, Ryu, Kyu-Hyung, Kang, Seok-Min, Kobashigawa, Jon A.

“…Malignancy is a concern in cardiac transplant recipients, but the temporal trends of de novo malignancy development are unknown. The goal of this study was to…”
Get full text

Recipient and surgical factors trigger severe primary graft dysfunction after heart transplant by Benck, Lillian, Kransdorf, Evan P., Emerson, Dominic A., Rushakoff, Joshua, Kittleson, Michelle M., Klapper, Ellen B., Megna, Dominick J., Esmailian, Fardad, Halprin, Chelsea, Trento, Alfredo, Ramzy, Danny, Czer, Lawrence S.C., Chang, David H., Ebinger, Joseph E., Kobashigawa, Jon A., Patel, Jignesh K.

“…Primary graft dysfunction (PGD) is a major cause of early mortality following heart transplant (HT). The International Society for Heart and Lung…”
Get full text

Asymptomatic Antibody-mediated Rejection After Heart Transplantation Predicts Poor Outcomes by Wu, Grace W., BS, Kobashigawa, Jon A., MD, Fishbein, Michael C., MD, Patel, Jignesh K., MD, PhD, Kittleson, Michelle M., MD, PhD, Reed, Elaine F., PhD, Kiyosaki, Krista K., BA, Ardehali, Abbas, MD

“…Background Antibody-mediated rejection (AMR) has been associated with poor outcome after heart transplantation. The diagnosis of AMR usually includes…”
Get full text

Angiotensin-Converting Enzyme Inhibition Early After Heart Transplantation by Fearon, William F., MD, Okada, Kozo, MD, Kobashigawa, Jon A., MD, Kobayashi, Yuhei, MD, Luikart, Helen, RN, Sana, Sean, MD, Daun, Tiffany, BSN, Chmura, Steven A., PhD, Sinha, Seema, MD, Cohen, Garett, BS, Honda, Yasuhiro, MD, Pham, Michael, MD, Lewis, David B., MD, Bernstein, Daniel, MD, Yeung, Alan C., MD, Valantine, Hannah A., MD, Khush, Kiran, MD, MAS

“…Abstract Background Cardiac allograft vasculopathy (CAV) remains a leading cause of mortality after heart transplantation (HT). Angiotensin-converting enzyme…”
Get full text

Early Denervation and Later Reinnervation of the Heart Following Cardiac Transplantation: A Review by Awad, Morcos, Czer, Lawrence S. C., Hou, Margaret, Golshani, Sarah S., Goltche, Michael, De Robertis, Michele, Kittleson, Michelle, Patel, Jignesh, Azarbal, Babak, Kransdorf, Evan, Esmailian, Fardad, Trento, Alfredo, Kobashigawa, Jon A.

Get full text

Intermediate Outcomes With Ex-Vivo Allograft Perfusion For Heart Transplantation by Chan, Joshua L., MD, Kobashigawa, Jon A., MD, Reich, Heidi J., MD, Ramzy, Danny, MD, PhD, Thottam, Maria M., BS, Yu, Zhe, MD, MPH, Aintablian, Tamar L., BS, Liou, Frank, BS, Patel, Jignesh K., MD, PhD, Kittleson, Michelle M., MD, PhD, Czer, Lawrence S., MD, Trento, Alfredo, MD, Esmailian, Fardad, MD

“…Background The Organ Care System, an ex-vivo heart perfusion platform, represents an alternative to the current standard of cold organ storage that sustains…”
Get full text

Effects of Older Donor Age and Cold Ischemic Time on Long-Term Outcomes of Heart Transplantation by Reich, Heidi J, Kobashigawa, Jon A, Aintablian, Tamar, Ramzy, Danny, Kittleson, Michelle M, Esmailian, Fardad

“…Using older donor hearts in cardiac transplantation may lead to inferior outcomes: older donors have more comorbidities that reduce graft quality, including…”
Get full text

Impact of the United Network for organ sharing 2018 donor heart allocation system on transplant morbidity and mortality by Stern, Lily K., Velleca, Angela, Nishihara, Keith, Shen, Adriana, Zaliznyak, Michael, Patel, Jignesh, Hamilton, Michele A., Ramzy, Danny, Esmailian, Fardad, Kobashigawa, Jon A., Kittleson, Michelle M.

“…Background While the revised UNOS HTx donor allocation system aimed to minimize waitlist mortality by prioritizing more critically ill transplant candidates,…”
Get full text

Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation by Cheng, Richard, Tank, Rikin, Ramzy, Danny, Azarbal, Babak, Chung, Joshua, Esmailian, Fardad, Kobashigawa, Jon A, Moriguchi, Jaime D, Arabia, Francisco A

“…Temporary mechanical circulatory support (MCS) can be a bridge to decision for patients in severe cardiogenic shock who may be eligible for durable support or…”
Get full text

Transplant centers that assess frailty as part of clinical practice have better outcomes by Chen, Xiaomeng, Liu, Yi, Thompson, Valerie, Chu, Nadia M, King, Elizabeth A, Walston, Jeremy D, Kobashigawa, Jon A, Dadhania, Darshana M, Segev, Dorry L, McAdams-DeMarco, Mara A

“…Frailty predicts adverse post-kidney transplant (KT) outcomes, yet the impact of frailty assessment on center-level outcomes remains unclear. We sought to test…”
Get full text

The impact of depression on heart transplant outcomes: A retrospective single‐center cohort study by Rosa, Angelo, Singer‐Englar, Tahli, Hamilton, Michele A., IsHak, Waguih William, Kobashigawa, Jon A., Kittleson, Michelle M.

“…Background Depression is prevalent in patients with heart failure and after heart transplant. We identified the prevalence of pre‐ and post‐transplant…”
Get full text

Continuing the pursuit of heart transplant antibody-mediated rejection by Kobashigawa, Jon A., MD

Get full text

HLA and MICA: Targets of Antibody-Mediated Rejection in Heart Transplantation by QIUHENG ZHANG, CECKA, J. Michael, GJERTSON, David W, PING GE, ROSE, Marlene L, PATEL, Jignesh K, ARDEHALI, Abbas, KOBASHIGAWA, Jon A, FISHBEIN, Michael C, REED, Elaine F

“…The goal of this study was to determine whether antidonor antibodies directed against human leukocyte antigen (HLA) or endothelial cells (ECs) expressed…”
Get full text

Cardiac magnetic resonance: Is it time to replace the endomyocardial biopsy to detect heart transplant rejection? by Kobashigawa, Jon A., MD

Get full text

Combined Heart and Kidney Transplantation: Clinical Experience in 100 Consecutive Patients by Awad, Morcos Atef, Czer, Lawrence S C, Emerson, Dominic, Jordan, Stanley, De Robertis, Michele A, Mirocha, James, Kransdorf, Evan, Chang, David H, Patel, Jignesh, Kittleson, Michelle, Ramzy, Danny, Chung, Joshua S, Cohen, J Louis, Esmailian, Fardad, Trento, Alfredo, Kobashigawa, Jon A

“…Background Combined heart and kidney transplantation ( HKT x) is performed in patients with severe heart failure and advanced renal insufficiency. We analyzed…”
Get full text